Clinical Trial Update: PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III [NA]

View source ↗

Summary

PROACTIVE-HF-2 is a heart failure clinical trial enrolling patients with NYHA class II and III and is currently recruiting. The sponsor listed is Endotronix, In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Endotronix, Inc. | Conditions: Heart Failure NYHA Class II, Heart Failure NYHA Class III | NA | Status: RECRUITING